Concurrent chemoradiotherapy for patients with locally advanced head & neck squamous cell carcinoma (LA-HNSCC)

Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT in patients with unresectable LA-HNSCC. Patients & Method: FP-RT: 5-FU 200mg/m2 (Day 1-6, 8-13, 35 -40, 42-47: CI), CDDP 40mg/m2 (Day 1,...

Full description

Saved in:
Bibliographic Details
Published inOTOLOGIA FUKUOKA Vol. 46; no. 4Supplement2; pp. S68 - S70
Main Author FUJII, Hirofumi
Format Journal Article
LanguageJapanese
Published JIBI TO RINSHO KAI 20.09.2000
Subjects
Online AccessGet full text
ISSN0447-7227
2185-1034
DOI10.11334/jibi1954.46.4Supplement2_S68

Cover

Abstract Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT in patients with unresectable LA-HNSCC. Patients & Method: FP-RT: 5-FU 200mg/m2 (Day 1-6, 8-13, 35 -40, 42-47: CI), CDDP 40mg/m2 (Day 1, 8, 35, 42), RT 2 Gy/day (Day 1-5, 8-12, 15-19, 35 -39, 42-46, 49-53). After radiation therapy to 60 Gy, patients were evaluated for response and those with CR at the primary site continued radiotherapy up to 66-72 Gy. Patients who achieved CR in primary site and had residual but resectable neck lymph nodes underwent neck dissection after completion of radiotherapy. Results: Patient characteristics were: F/M: 3/24, Age (median, range: 57, 41-67), Stage III/IV: 1/26. Hematological toxicities include: 7% grade 4 leukopenia and neutropenia, 44% grade 3 anemia and 4% grade 4 thrombocytopenia. Grade 3 mucositis was seen in 70%. Two patients died with methicillin resistance Staphylococcus aureus pneumonia. After FP-RT, overall response rate was 85% including 22% CR. CR rate of primary site and that of lymph nodes were 60% and 30%, respectively. 3/4 patients who underwent radical neck resection had residual tumor. Laryngeal preservation rate at 1 year was 44% in patients who were followed more than 1 year. Finally overall CR rate was 33%. Median survival time was 11 months. Conclusion: Although supportive cares were very difficult, FP-RT was the feasible and tolerable treatment. After FP-RT, there were no major complication for neck dissection, but it was very difficult to perform the modified neck dissection. FP-RT was one of the effective regimen for laryngeal preservation in the treatment of LA-HNSCC.
AbstractList Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT in patients with unresectable LA-HNSCC. Patients & Method: FP-RT: 5-FU 200mg/m2 (Day 1-6, 8-13, 35 -40, 42-47: CI), CDDP 40mg/m2 (Day 1, 8, 35, 42), RT 2 Gy/day (Day 1-5, 8-12, 15-19, 35 -39, 42-46, 49-53). After radiation therapy to 60 Gy, patients were evaluated for response and those with CR at the primary site continued radiotherapy up to 66-72 Gy. Patients who achieved CR in primary site and had residual but resectable neck lymph nodes underwent neck dissection after completion of radiotherapy. Results: Patient characteristics were: F/M: 3/24, Age (median, range: 57, 41-67), Stage III/IV: 1/26. Hematological toxicities include: 7% grade 4 leukopenia and neutropenia, 44% grade 3 anemia and 4% grade 4 thrombocytopenia. Grade 3 mucositis was seen in 70%. Two patients died with methicillin resistance Staphylococcus aureus pneumonia. After FP-RT, overall response rate was 85% including 22% CR. CR rate of primary site and that of lymph nodes were 60% and 30%, respectively. 3/4 patients who underwent radical neck resection had residual tumor. Laryngeal preservation rate at 1 year was 44% in patients who were followed more than 1 year. Finally overall CR rate was 33%. Median survival time was 11 months. Conclusion: Although supportive cares were very difficult, FP-RT was the feasible and tolerable treatment. After FP-RT, there were no major complication for neck dissection, but it was very difficult to perform the modified neck dissection. FP-RT was one of the effective regimen for laryngeal preservation in the treatment of LA-HNSCC. 局所進行頭頸部扁平上皮癌を対象にCDDP/5-FU併用放射線療法を行い、その安全性・有効性について検討した。病状による呼吸・栄養・瘍痛管理が当初から必要で、補助療法が困難を極める症例が多くを占めた。急性毒性としてはgrade4の好中球減少が7%、grade3の口内炎、咽頭炎が70%に認められた。晩期反応としては唾液減少による口渇が認められた。奏功率85%、CR率22%であり、MSTは11カ月であった。治療開始から1年以上経過した18例中8人が生存中で全例喉頭機能が温存されている。管理は難しいもののこの治療法は耐用性があり、局所進行頭頸部癌に対しては生存率・喉頭機能温存においても有用な方法であると考えられた。
Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT in patients with unresectable LA-HNSCC. Patients & Method: FP-RT: 5-FU 200mg/m2 (Day 1-6, 8-13, 35 -40, 42-47: CI), CDDP 40mg/m2 (Day 1, 8, 35, 42), RT 2 Gy/day (Day 1-5, 8-12, 15-19, 35 -39, 42-46, 49-53). After radiation therapy to 60 Gy, patients were evaluated for response and those with CR at the primary site continued radiotherapy up to 66-72 Gy. Patients who achieved CR in primary site and had residual but resectable neck lymph nodes underwent neck dissection after completion of radiotherapy. Results: Patient characteristics were: F/M: 3/24, Age (median, range: 57, 41-67), Stage III/IV: 1/26. Hematological toxicities include: 7% grade 4 leukopenia and neutropenia, 44% grade 3 anemia and 4% grade 4 thrombocytopenia. Grade 3 mucositis was seen in 70%. Two patients died with methicillin resistance Staphylococcus aureus pneumonia. After FP-RT, overall response rate was 85% including 22% CR. CR rate of primary site and that of lymph nodes were 60% and 30%, respectively. 3/4 patients who underwent radical neck resection had residual tumor. Laryngeal preservation rate at 1 year was 44% in patients who were followed more than 1 year. Finally overall CR rate was 33%. Median survival time was 11 months. Conclusion: Although supportive cares were very difficult, FP-RT was the feasible and tolerable treatment. After FP-RT, there were no major complication for neck dissection, but it was very difficult to perform the modified neck dissection. FP-RT was one of the effective regimen for laryngeal preservation in the treatment of LA-HNSCC.
Author FUJII, Hirofumi
Author_FL 藤井 博文
Author_FL_xml – sequence: 1
  fullname: 藤井 博文
Author_xml – sequence: 1
  fullname: FUJII, Hirofumi
  organization: Division of Oncology/Hematology, National Cancer Center Hospital
BackLink https://cir.nii.ac.jp/crid/1390001205499339392$$DView record in CiNii
BookMark eNpVkE1LxEAMhgdRcP34D3NQ0UPX-Wq3c5SirrDqYb2XNE3trO20TrvK_nsLfoCXhPA-CeE5Yvu-88TYuRRzKbU21xtXOGljMzfJ3Ky3fd9QS35U-TpJ99hMyTSOpNBmn82EMYtoodTikJ0OgyuEUEIYleoZ81nncRvCtMmxprYLULpurClAv-NVF3gPo5vSgX-6seZNh9A0Ow7lB3ikktcEJb_gnvCND-9baLvtwJGahiMEdL5rgV-ubqLl0zrLrk7YQQXNQKc__Zi93N2-ZMto9Xz_kN2soo21KtIaEqtkYtKUpMEyAbSEUBSikmCtUVosUGisEOMykbZChbpKgKSSEFOhj9nZ91nvXD49MVWprRBCKhEba7W22qoJe_zGNsMIr5T3wbUQdjmE0WFD-a_i3CT5P8XTPFn-47CGkJPXX29bfjk
ContentType Journal Article
Copyright JIBI TO RINSHO KAI
Copyright_xml – notice: JIBI TO RINSHO KAI
DBID RYH
DOI 10.11334/jibi1954.46.4Supplement2_S68
DatabaseName CiNii Complete
DatabaseTitleList

DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate 局所進行頭頸部扁平上皮癌に対する化学療法併用放射線療法
DocumentTitle_FL 局所進行頭頸部扁平上皮癌に対する化学療法併用放射線療法
EISSN 2185-1034
EndPage S70
ExternalDocumentID 130004133494
article_jibi1954_46_4Supplement2_46_S68_article_char_en
GroupedDBID ABJNI
ACGFS
ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
RJT
RYH
ID FETCH-LOGICAL-j992-33a69216488e14cd6ac9ecabb0f1a9942307c03cfcc5d619fc2c3f6ae121a5eb3
ISSN 0447-7227
IngestDate Thu Jun 26 22:54:12 EDT 2025
Wed Sep 03 06:30:45 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue 4Supplement2
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j992-33a69216488e14cd6ac9ecabb0f1a9942307c03cfcc5d619fc2c3f6ae121a5eb3
OpenAccessLink https://www.jstage.jst.go.jp/article/jibi1954/46/4Supplement2/46_S68/_article/-char/en
ParticipantIDs nii_cinii_1390001205499339392
jstage_primary_article_jibi1954_46_4Supplement2_46_S68_article_char_en
PublicationCentury 2000
PublicationDate 2000/09/20
PublicationDateYYYYMMDD 2000-09-20
PublicationDate_xml – month: 09
  year: 2000
  text: 2000/09/20
  day: 20
PublicationDecade 2000
PublicationTitle OTOLOGIA FUKUOKA
PublicationTitleAlternate jibi to rinsho
PublicationTitle_FL 耳鼻と臨床
耳鼻
OTOLOGIA FUKUOKA
PublicationYear 2000
Publisher JIBI TO RINSHO KAI
Publisher_xml – name: JIBI TO RINSHO KAI
SSID ssib002004283
ssj0000400194
ssib005879669
ssib058493091
Score 1.3576077
Snippet Background: Concurrent chemoradiation improves survival over radiation alone in unresectable HNSCC. We evaluated the efficacy and toxicity of concurrent FP-RT...
SourceID nii
jstage
SourceType Publisher
StartPage S68
SubjectTerms シスプラチン
フルオロウラシル
化学療法併用放射線療法
局所進行頭頸部癌
Title Concurrent chemoradiotherapy for patients with locally advanced head & neck squamous cell carcinoma (LA-HNSCC)
URI https://www.jstage.jst.go.jp/article/jibi1954/46/4Supplement2/46_S68/_article/-char/en
https://cir.nii.ac.jp/crid/1390001205499339392
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX jibi to rinsho, 2000/09/20, Vol.46(4Supplement2), pp.S68-S70
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2185-1034
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000400194
  issn: 0447-7227
  databaseCode: KQ8
  dateStart: 19540101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELa6ISFeJhAgBgz5ARAoSnFi59fjqJiaTXSCdtLeIsdxtBSajq19gH-Cf5k7x0lTDSGYeLFaq3Zq39fz3dX3HSEvtQ5VngTc5eBruCJRhRvnTLhBHkc-F0rKABOFP07C8Zk4Pg_OB4OfvVtL61U-VD9-m1dyG6lCH8gVs2T_QbLdpNABr0G-0IKEof0rGY-WtbL8SrD3C5BmUdmMquYepmVNtSls5tz6-n3zvz8o4sLIvtbqi3P9bS0xEOBgMB8pq1VVLxfSFP04dMeT6WjUxg2sNTuv8gqN16uqvr5YdlA4O05Tc6RVoOTXi2orssDwGoTPNlo_fZ86s1PnczqZjk-dE8tO3egmISI38pu0_qE2fWAsIKmpjU1a5Wrjiw2IhKlUasKefk9pTpvCOvb8nTaFRG6qds4F6nZYGbLUDUU47M-XdbNssWdb2WTtsEyE2dYweA8js_ZzmOsG0Nohd3w4JrAWyMmnnj9mXMyeQosjcBc7exCMuYQzSz5kTAGBJrShMGs37C551a7m3Z_WAhbRHPwDJH7YqauqZ_TM7pM9663Qw-ZrPyCDuXxI6g3s6A3YUYAdbWFHEXbUwo62sKMIO_qaIuhoCzqKoKMd6OibFnJvH5HZ0YfZaOzash3uHK8ycy7DxAcvPI61J1QRSpVoJfOclZ5MEoGZB4pxVSoVFOC-l8pXvAyl9nwPFEPOH5PdelnrJ4TqPAqk9FlYRAHy6CVMMV9LLqQKy1h6--So2aPssqFmyW4p7n1yAHucwQqhBZ_IxGcZhk44T8CDePq_HvSM3Nv80p6T3dXVWh-AVbvKXxik_QLGMKMW
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Concurrent+chemoradiotherapy+for+patients+with+locally+advanced+head+%26+neck+squamous+cell+carcinoma+%28LA-HNSCC%29&rft.jtitle=jibi+to+rinsho&rft.au=FUJII%2C+Hirofumi&rft.date=2000-09-20&rft.pub=JIBI+TO+RINSHO+KAI&rft.issn=0447-7227&rft.eissn=2185-1034&rft.volume=46&rft.issue=4Supplement2&rft.spage=S68&rft.epage=S70&rft_id=info:doi/10.11334%2Fjibi1954.46.4Supplement2_S68&rft.externalDocID=article_jibi1954_46_4Supplement2_46_S68_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0447-7227&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0447-7227&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0447-7227&client=summon